Diabetes, Vol 48, Issue 4 775-782, Copyright © 1999 by American Diabetes Association

ARTICLES

Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle

TS Tsao, AE Stenbit, SM Factor, W Chen, L Rossetti and MJ Charron
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Impaired skeletal muscle glucose utilization under insulin action is a major defect in the etiology of type 2 diabetes. This is underscored by a new mouse model of type 2 diabetes generated by genetic disruption of one allele of glucose transporter 4 (GLUT4+/-), the insulin-responsive glucose transporter in muscle and adipose tissue. Male GLUT4+/- mice exhibited decreased GLUT4 expression and glucose uptake in muscle that accompanied impaired whole-body glucose utilization, hyperinsulinemia, hyperglycemia, and heart histopathology. To determine whether development of the diabetic phenotype in GLUT4+/- mice can be forestalled by preventing the onset of impaired muscle GLUT4 expression and glucose utilization, standard genetic crossing was performed to introduce a fast-twitch muscle-specific GLUT4 transgene--the myosin light chain (MLC) promoter-driven transgene MLC-GLUT4--into GLUT4+/- mice (MLC-GLUT4+/- mice). GLUT4 expression and 2-deoxyglucose uptake levels were normalized in fast-twitch muscles of MLC-GLUT4+/- mice. In contrast to GLUT4+/- mice, MLC-GLUT4+/- mice exhibited normal whole-body glucose utilization. In addition, development of hyperinsulinemia and hyperglycemia observed in GLUT4+/- mice was prevented in MLC-GLUT4+/- mice. The occurrence of diabetic heart histopathology in MLC-GLUT4+/- mice was reduced to control levels. Based on these results, we propose that the onset of a diabetic phenotype in GLUT4+/- mice can be avoided by preventing decreases in muscle GLUT4 expression and glucose uptake.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. T. Fueger, H. S. Hess, K. A. Posey, D. P. Bracy, R. R. Pencek, M. J. Charron, and D. H. Wasserman Control of Exercise-stimulated Muscle Glucose Uptake by GLUT4 Is Dependent on Glucose Phosphorylation Capacity in the Conscious Mouse J. Biol. Chem., December 3, 2004; 279(49): 50956 - 50961. [Abstract] [Full Text] [PDF]

				P. T. Fueger, H. S. Hess, D. P. Bracy, R. R. Pencek, K. A. Posey, M. J. Charron, and D. H. Wasserman Regulation of Insulin-Stimulated Muscle Glucose Uptake in the Conscious Mouse: Role of Glucose Transport Is Dependent on Glucose Phosphorylation Capacity Endocrinology, November 1, 2004; 145(11): 4912 - 4916. [Abstract] [Full Text] [PDF]

				Y. Minokoshi, C. R. Kahn, and B. B. Kahn Tissue-specific Ablation of the GLUT4 Glucose Transporter or the Insulin Receptor Challenges Assumptions about Insulin Action and Glucose Homeostasis J. Biol. Chem., September 5, 2003; 278(36): 33609 - 33612. [Full Text] [PDF]

				P. Valet, G. Tavernier, I. Castan-Laurell, J. S. Saulnier-Blache, and D. Langin Understanding adipose tissue development from transgenic animal models J. Lipid Res., June 1, 2002; 43(6): 835 - 860. [Abstract] [Full Text] [PDF]

				M. Gaster, P. Staehr, H. Beck-Nielsen, H. D. Schrøder, and A. Handberg GLUT4 Is Reduced in Slow Muscle Fibers of Type 2 Diabetic Patients: Is Insulin Resistance in Type 2 Diabetes a Slow, Type 1 Fiber Disease? Diabetes, June 1, 2001; 50(6): 1324 - 1329. [Abstract] [Full Text]

				T.-S. TSAO, J. LI, K. S. CHANG, A. E. STENBIT, D. GALUSKA, J. E. ANDERSON, J. R. ZIERATH, R. J. MCCARTER, and M. J. CHARRON Metabolic adaptations in skeletal muscle overexpressing GLUT4: effects on muscle and physical activity FASEB J, April 1, 2001; 15(6): 958 - 969. [Abstract] [Full Text] [PDF]

				M. Gaster, P. Poulsen, A. Handberg, H. D. Schroder, and H. Beck-Nielsen Direct evidence of fiber type-dependent GLUT-4 expression in human skeletal muscle Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E910 - E916. [Abstract] [Full Text] [PDF]